MedTrace Logo

Artificial Intelligence Education and Climate Awareness in Pregnancy

NCT07541885 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2026-04-21

No results posted yet for this study

Summary

This quasi-experimental pretest-posttest study aimed to evaluate the effect of artificial intelligence-assisted climate change education on pregnant women's climate change concerns and awareness. The study will be conducted with pregnant women attending a pregnancy school, and participants will be assigned to intervention and control groups. The intervention group will receive AI-supported climate change education in addition to routine training, while the control group will receive only routine education. Data will be collected using the Climate Change Anxiety Scale and the Maternal-Fetal Health Awareness of Climate Change Scale. The findings are expected to contribute to improving pregnant women's awareness and reducing concerns related to climate change through innovative educational approaches.

Conditions

  • Climate Change
  • Maternal Health
  • Fetal Health
  • Midwifery
  • Artificial Intelligence (AI)

Interventions

OTHER

Intervention 1

Participants in the intervention group will receive routine education provided in the Pregnancy School program in addition to an artificial intelligence-assisted educational video about climate change and its effects on maternal and fetal health. The education will be delivered during scheduled sessions, and participants will complete pretest and posttest assessments measuring climate change concerns and awareness.

OTHER

Control

Participants in the control group will receive only the routine education provided in the Pregnancy School program without any additional artificial intelligence-assisted educational intervention. Pretest and posttest assessments will also be conducted in this group to evaluate climate change concerns and awareness.

Sponsors & Collaborators

  • Derya Kaya Senol

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-04-01
Primary Completion
2026-07-01
Completion
2026-07-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07541885 on ClinicalTrials.gov